209 related articles for article (PubMed ID: 17520544)
1. Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient.
Kamboj M; Sepkowitz KA
Infect Control Hosp Epidemiol; 2007 Jun; 28(6):702-7. PubMed ID: 17520544
[TBL] [Abstract][Full Text] [Related]
2. Intranasal live attenuated seasonal influenza vaccine: does not challenge current practice.
Prescrire Int; 2013 Sep; 22(141):201-4. PubMed ID: 24171209
[TBL] [Abstract][Full Text] [Related]
3. [Vaccination].
Graubner UB; Liese J; Belohradsky BH
Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts.
; Shearer WT; Fleisher TA; Buckley RH; Ballas Z; Ballow M; Blaese RM; Bonilla FA; Conley ME; Cunningham-Rundles C; Filipovich AH; Fuleihan R; Gelfand EW; Hernandez-Trujillo V; Holland SM; Hong R; Lederman HM; Malech HL; Miles S; Notarangelo LD; Ochs HD; Orange JS; Puck JM; Routes JM; Stiehm ER; Sullivan K; Torgerson T; Winkelstein J
J Allergy Clin Immunol; 2014 Apr; 133(4):961-6. PubMed ID: 24582311
[TBL] [Abstract][Full Text] [Related]
5. Immunization in the adult immunocompromised host.
Löbermann M; Boršo D; Hilgendorf I; Fritzsche C; Zettl UK; Reisinger EC
Autoimmun Rev; 2012 Jan; 11(3):212-8. PubMed ID: 21621004
[TBL] [Abstract][Full Text] [Related]
6. Cold-adapted, live attenuated influenza vaccine.
Glezen WP
Expert Rev Vaccines; 2004 Apr; 3(2):131-9. PubMed ID: 15056039
[TBL] [Abstract][Full Text] [Related]
7. [Vaccination against varicella].
Magdzik W
Przegl Epidemiol; 1995; 49(3):321-4. PubMed ID: 7491430
[TBL] [Abstract][Full Text] [Related]
8. The status of live viral vaccination in early life.
Gans HA
Vaccine; 2013 May; 31(21):2531-7. PubMed ID: 23026688
[TBL] [Abstract][Full Text] [Related]
9. Transmissible vaccines whose dissemination rates vary through time, with applications to wildlife.
Smithson MW; Basinki AJ; Nuismer SL; Bull JJ
Vaccine; 2019 Feb; 37(9):1153-1159. PubMed ID: 30686635
[TBL] [Abstract][Full Text] [Related]
10. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
[TBL] [Abstract][Full Text] [Related]
11. Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques.
Edghill-Smith Y; Venzon D; Karpova T; McNally J; Nacsa J; Tsai WP; Tryniszewska E; Moniuszko M; Manischewitz J; King LR; Snodgrass SJ; Parrish J; Markham P; Sowers M; Martin D; Lewis MG; Berzofsky JA; Belyakov IM; Moss B; Tartaglia J; Bray M; Hirsch V; Golding H; Franchini G
J Infect Dis; 2003 Oct; 188(8):1181-91. PubMed ID: 14551889
[TBL] [Abstract][Full Text] [Related]
12. Live viral vaccines in transplanted patients.
L'Huillier AG; Posfay Barbe K
Swiss Med Wkly; 2014; 144():w14005. PubMed ID: 25341637
[TBL] [Abstract][Full Text] [Related]
13. Live attenuated vaccines: Historical successes and current challenges.
Minor PD
Virology; 2015 May; 479-480():379-92. PubMed ID: 25864107
[TBL] [Abstract][Full Text] [Related]
14. State of the art: Could nursing mothers be vaccinated with attenuated live virus vaccine?
Alain S; Dommergues MA; Jacquard AC; Caulin E; Launay O
Vaccine; 2012 Jul; 30(33):4921-6. PubMed ID: 22659446
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the immune responses in BALB/c mice following immunization with DNA-based and live attenuated vaccines delivered via different routes.
Cai MS; Deng SX; Li ML
Vaccine; 2013 Feb; 31(9):1353-6. PubMed ID: 22995858
[TBL] [Abstract][Full Text] [Related]
16. Live attenuated and inactivated viral vaccine formulation and nasal delivery: potential and challenges.
Tlaxca JL; Ellis S; Remmele RL
Adv Drug Deliv Rev; 2015 Oct; 93():56-78. PubMed ID: 25312673
[TBL] [Abstract][Full Text] [Related]
17. [Better vaccinations - new approaches for targeted immunomodulation in healthy and immunosuppressed].
Balmer ML; Berger CT
Ther Umsch; 2014 Jan; 71(1):5-15. PubMed ID: 24394204
[TBL] [Abstract][Full Text] [Related]
18. Study of tolerance and effectiveness of a varicella vaccine in leukemic children.
Bancillon A; Leblanc T; Baruchel A; Schaison G; Leverger G; Mallarmey D; Teuliere L
Nouv Rev Fr Hematol (1978); 1991; 33(6):555-6. PubMed ID: 1667953
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
[TBL] [Abstract][Full Text] [Related]
20. Vaccination against acute respiratory virus infections and measles in man.
Osterhaus AD; de Vries P
Immunobiology; 1992 Feb; 184(2-3):180-92. PubMed ID: 1587542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
